Send to:

Choose Destination
See comment in PubMed Commons below
Tijdschr Gerontol Geriatr. 2009 Jun;40(3):133-7.

[Progressive supranucleair palsy: acetylcholineeserase-inhibitor a possible therapy?].

[Article in Dutch]

Author information

  • 1Klinisch geriater, GeheugenCentrum, Jeroen Bosch Ziekenhuis,'s Hertogenbosch.


Progressive supranucleair palsy (PSP) is a serious neurologic disease which is seldom diagnosed due to its complexity. In 1996 international diagnostic criteria were developed by a group of experts, the diagnosis remains complicated. We describe three cases, which were followed in the period 2001-2008. In these case reports we elaborate on the therapeutic use of rivastigmine. During off-label rivastigmine use, patients showed minimal further cognitive decline, specifically with respect to frontal defects. However, larger studies and trials are necessary to explore the effects of rivastigmine in patients with PSP.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk